BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18843491)

  • 1. [Predictive and prognostic markers of breast cancer. Molecular biological analysis of fixed tumor tissue].
    Petry C; Gehrmann M; von Törne C; Weber K; Stropp U; Hennig G
    Pathologe; 2008 Nov; 29 Suppl 2():181-3. PubMed ID: 18843491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
    Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
    J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer.
    Paik S; Kim CY; Song YK; Kim WS
    Nat Clin Pract Oncol; 2005 May; 2(5):246-54. PubMed ID: 16264960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of breast cancer using genetic algorithms and tissue microarrays.
    Dolled-Filhart M; Rydén L; Cregger M; Jirström K; Harigopal M; Camp RL; Rimm DL
    Clin Cancer Res; 2006 Nov; 12(21):6459-68. PubMed ID: 17085660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.
    Sánchez-Navarro I; Gámez-Pozo A; González-Barón M; Pinto-Marín A; Hardisson D; López R; Madero R; Cejas P; Mendiola M; Espinosa E; Vara JA
    Biotechniques; 2010 May; 48(5):389-97. PubMed ID: 20569212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
    Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary comparison of quantity, quality, and microarray performance of RNA extracted from formalin-fixed, paraffin-embedded, and unfixed frozen tissue samples.
    Scicchitano MS; Dalmas DA; Bertiaux MA; Anderson SM; Turner LR; Thomas RA; Mirable R; Boyce RW
    J Histochem Cytochem; 2006 Nov; 54(11):1229-37. PubMed ID: 16864893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
    Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples.
    Ciotti P; Garuti A; Ballestrero A; Cirmena G; Chiaramondia M; Baccini P; Bellone E; Mandich P
    Diagn Mol Pathol; 2009 Jun; 18(2):112-8. PubMed ID: 19430292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens.
    Ibusuki M; Fu P; Yamamoto S; Fujiwara S; Yamamoto Y; Honda Y; Iyama K; Iwase H
    Breast Cancer; 2013 Apr; 20(2):159-66. PubMed ID: 22139726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will PAXgene substitute formalin? A morphological and molecular comparative study using a new fixative system.
    Belloni B; Lambertini C; Nuciforo P; Phillips J; Bruening E; Wong S; Dummer R
    J Clin Pathol; 2013 Feb; 66(2):124-35. PubMed ID: 23125305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.
    Jacobs S; Thompson ER; Nannya Y; Yamamoto G; Pillai R; Ogawa S; Bailey DK; Campbell IG
    Cancer Res; 2007 Mar; 67(6):2544-51. PubMed ID: 17363572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy.
    Paik S
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1019s-1023s. PubMed ID: 16467119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues.
    Chen J; Byrne GE; Lossos IS
    Diagn Mol Pathol; 2007 Jun; 16(2):61-72. PubMed ID: 17525674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative expression profiling of RNA from formalin-fixed, paraffin-embedded tissues using randomly assembled bead arrays.
    Bibikova M; Yeakley JM; Wang-Rodriguez J; Fan JB
    Methods Mol Biol; 2008; 439():159-77. PubMed ID: 18370102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercialized multigene predictors of clinical outcome for breast cancer.
    Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
    Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues.
    Lyons-Weiler M; Hagenkord J; Sciulli C; Dhir R; Monzon FA
    Diagn Mol Pathol; 2008 Mar; 17(1):3-13. PubMed ID: 18303412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.